Terms: = Bone cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
141 results:
1. Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients.
Schmälter AK; Ngoya M; Galimard JE; Bazarbachi A; Finke J; Kröger N; Bornhäuser M; Stelljes M; Stölzel F; Tischer J; Schroeder T; Dreger P; Blau IW; Savani B; Giebel S; Esteve J; Nagler A; Schmid C; Ciceri F; Mohty M
Blood Cancer J; 2024 May; 14(1):76. PubMed ID: 38697960
[TBL] [Abstract] [Full Text] [Related]
2. A pictorial view on false positive findings of
Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
[TBL] [Abstract] [Full Text] [Related]
3. PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation.
Penack O; Abouqateb M; Peczynski C; Boreland W; Gülbas Z; Gedde-Dahl T; Castilla-Llorente C; Kröger N; Eder M; Rambaldi A; Bonifazi F; Blau IW; Stelljes M; Dreger P; Moiseev I; Schoemans H; Koenecke C; Peric Z
Blood Cancer J; 2024 Mar; 14(1):45. PubMed ID: 38485723
[TBL] [Abstract] [Full Text] [Related]
4. Malignant myoepithelioma of the external auditory canal - a rare case report with literature review and clinical importance of foramen of Huschke.
Mateášiková Z; Salzman R; Michálek J
World J Surg Oncol; 2024 Jan; 22(1):28. PubMed ID: 38268020
[TBL] [Abstract] [Full Text] [Related]
5. The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Visentin A; Chatzikonstantinou T; Scarfò L; Kapetanakis A; Demosthenous C; Karakatsoulis G; Minga E; Chamou D; Allsup D; Cabrero AA; Andres M; Antic D; Baile M; Baliakas P; Besikli-Dimou S; Bron D; Chatzileontiadou S; Cordoba R; Correa JG; Cuéllar-García C; De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Frederiksen H; Fürstenau M; García-Marco JA; García-Serra R; Collado R; Gentile M; Gimeno E; Glenthøj A; da Silva MG; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Innocenti I; Itchaki G; Jaksic O; Janssens A; Kalashnikova ОB; Kalicińska E; Kater AP; Kersting S; Labrador J; Lad D; Laurenti L; Levin MD; Lista E; Lopez-Garcia A; Malerba L; Marasca R; Marchetti M; Marquet J; Mattsson M; Mauro FR; Morawska M; Motta M; Munir T; Murru R; Niemann CU; Rodrigues RN; Olivieri J; Orsucci L; Papaioannou M; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Qvist K; Rigolin GM; Ruchlemer R; Šimkovič M; Špaček M; Sportoletti P; Stanca O; Tadmor T; Capasso A; Del Poeta G; Gutwein O; Karlsson LK; Milosevic I; Mirás F; Reda G; Saghumyan G; Shrestha A; Te Raa D; Tonino SH; Van Der Spek E; van Gelder M; van Kampen R; Wasik-Szczepanek E; Wróbel T; Segundo LYS; Yassin M; Pocali B; Vandenberghe E; Iyengar S; Varettoni M; Vitale C; Coscia M; Rambaldi A; Montserrat E; Cuneo A; Stavroyianni N; Trentin L; Stamatopoulos K; Ghia P
Am J Hematol; 2023 Dec; 98(12):1856-1868. PubMed ID: 37772428
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of spread and anatomical prognostic factors of pre-auricular cutaneous squamous cell carcinoma extending to the temporal bone.
Schachtel MJC; Gandhi M; Bowman JJ; Panizza BJ
Head Neck; 2023 Nov; 45(11):2893-2906. PubMed ID: 37737376
[TBL] [Abstract] [Full Text] [Related]
7. cyld stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
[TBL] [Abstract] [Full Text] [Related]
8. Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.
Arbore G; Albarello L; Bucci G; Punta M; Cossu A; Fanti L; Maurizio A; Di Mauro F; Bilello V; Arrigoni G; Bonfiglio S; Biancolini D; Puccetti F; Elmore U; Vago L; Cascinu S; Tonon G; Rosati R; Casorati G; Dellabona P
Cancer Res; 2023 Sep; 83(17):2873-2888. PubMed ID: 37350667
[TBL] [Abstract] [Full Text] [Related]
9. Questioning the value of stalk drilling after external auditory canal osteoma excision: case series, literature review, and meta-analysis.
Argaman A; Oron Y; Handzel O; Abu-Eta R; Muhanna N; Halpern D; Ungar OJ
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):51-59. PubMed ID: 37335347
[TBL] [Abstract] [Full Text] [Related]
10. Signaling Pathways in the Pathogenesis of Barrett's Esophagus and Esophageal Adenocarcinoma.
Maslenkina K; Mikhaleva L; Naumenko M; Vandysheva R; Gushchin M; Atiakshin D; Buchwalow I; Tiemann M
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298253
[TBL] [Abstract] [Full Text] [Related]
11. Clinical outcome and prognostic factors in adenoid cystic carcinoma of the external auditory canal: proposal for a refined T-stage classification system.
Lee JY; Cho YS
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3625-3633. PubMed ID: 36781438
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of Prognostic Factors For External Auditory Canal Carcinoma: A 22-Year Experience.
Jang IJH; Thong JF; Teo CEH; Sommat K
Laryngoscope; 2023 Sep; 133(9):2203-2210. PubMed ID: 36478582
[TBL] [Abstract] [Full Text] [Related]
13. The expression of miR-181b, cyld, CBX-7, BCL2, and p53 in osteosarcoma patients and correlation with clinicopathological factors.
Fazli J; Fattah K; Moliani A; Valizadeh A; Bazavar M
Chem Biol Drug Des; 2023 Jan; 101(1):2-8. PubMed ID: 36098711
[TBL] [Abstract] [Full Text] [Related]
14. Beneficial Modulatory Effects of Treatment With bone Marrow Lysate on Hematopoietic Stem Cells and Myeloid Cells in Tumor-Bearing Mice.
Salem ML; El-Bakry KA; Moubark EH; Sobh A; Khalil SM
Br J Biomed Sci; 2022; 79():10328. PubMed ID: 35996501
[No Abstract] [Full Text] [Related]
15. Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.
Li S; Hoefnagel SJM; Read M; Meijer S; van Berge Henegouwen MI; Gisbertz SS; Bonora E; Liu DSH; Phillips WA; Calpe S; Correia ACP; Sancho-Serra MDC; Mattioli S; Krishnadath KK;
Cell Oncol (Dordr); 2022 Aug; 45(4):639-658. PubMed ID: 35902550
[TBL] [Abstract] [Full Text] [Related]
16. Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin.
Hosseini F; Shanehbandi D; Soleimanpour J; Yousefi B; Alemi F
Drug Res (Stuttg); 2022 Jul; 72(6):312-318. PubMed ID: 35636434
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.
Nabuurs CH; Kievit W; Leemans CR; Smit CFGM; van den Brekel MWM; Pauw RJ; van der Laan BFAM; Jansen JC; Lacko M; Braunius WW; Dai C; Shi X; Danesi G; Bouček J; Takes RP; Kunst HPM
Head Neck; 2022 Aug; 44(8):1787-1798. PubMed ID: 35560966
[TBL] [Abstract] [Full Text] [Related]
18. Quercetin and Methotrexate in Combination have Anticancer Activity in Osteosarcoma Cells and Repress Oncogenic MicroRNA-223.
Mohammadi E; Alemi F; Maleki M; Malakoti F; Farsad-Akhtar N; Yousefi B
Drug Res (Stuttg); 2022 Apr; 72(4):226-233. PubMed ID: 35385884
[TBL] [Abstract] [Full Text] [Related]
19. Temporal bone Resection for Squamous Cell Carcinoma of the Lateral Skull Base: Systematic Review and Meta-analysis.
McCracken M; Pai K; Cabrera CI; Johnson BR; Tamaki A; Gidley PW; Manzoor NF
Otolaryngol Head Neck Surg; 2023 Feb; 168(2):154-164. PubMed ID: 35290141
[TBL] [Abstract] [Full Text] [Related]
20. Treatment Strategies for Malignancies of the External Auditory Canal.
Zhong S; Zuo W
Curr Treat Options Oncol; 2022 Jan; 23(1):43-53. PubMed ID: 35167009
[TBL] [Abstract] [Full Text] [Related]
[Next]
